ANROVSSXTC• 3 Months (Normalized)
ANRO vs SXTC (Alto Neuroscience Inc. vs China SXT Pharmaceuticals Inc.)
Showing Closing Date Range from Jun 30 to Sep 28, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
ANRO Performance $27.5
+4.21%
Alto Neuroscience Inc.
Normalized Baseline0.00%
SXTC Performance $2.51
-98.51%
China SXT Pharmaceuticals Inc.
Normalized Baseline0.00%
Alpha Spread Margin ANRO LEADS
+102.72 pts
ANRO outperforming by 102.72 percentage points
ANROSXTC
Spread Trajectory3 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
ANRO SXTC
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(60 dates)
| Date | ANRO Price | ANRO Gain (%) | SXTC Price | SXTC Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 23, 2026 | $27.50 | +4.21% | $2.51 | -98.51% | +102.72% |
| Sep 22, 2026 | $30.78 | +16.64% | $- | - | |
| Sep 21, 2026 | $30.63 | +16.07% | $2.38 | -98.59% | +114.66% |
| Sep 18, 2026 | $30.27 | +14.70% | $2.40 | -98.58% | +113.28% |
| Sep 17, 2026 | $30.98 | +17.39% | $2.44 | -98.56% | +115.95% |
| Sep 16, 2026 | $30.00 | +13.68% | $2.19 | -98.70% | +112.38% |
| Sep 15, 2026 | $30.25 | +14.63% | $2.36 | -98.60% | +113.23% |
| Sep 14, 2026 | $31.68 | +20.05% | $2.66 | -98.42% | +118.47% |
| Sep 11, 2026 | $32.00 | +21.26% | $2.56 | -98.48% | +119.74% |
| Sep 10, 2026 | $31.68 | +20.05% | $1.93 | -98.86% | +118.91% |
| Sep 09, 2026 | $34.07 | +29.10% | $2.14 | -98.73% | +127.83% |
| Sep 08, 2026 | $35.81 | +35.70% | $2.24 | -98.67% | +134.37% |
| Sep 04, 2026 | $35.55 | +34.71% | $2.23 | -98.68% | +133.39% |
| Sep 03, 2026 | $36.40 | +37.93% | $2.20 | -98.70% | +136.63% |
| Sep 02, 2026 | $36.64 | +38.84% | $2.22 | -98.68% | +137.52% |
Page 1 of 4